US Stock MarketDetailed Quotes

KRON Kronos Bio

Watchlist
  • 0.950
  • -0.040-4.05%
Trading Nov 4 12:40 ET
57.27MMarket Cap-545P/E (TTM)

Kronos Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
44.21%2.69M
106.39%2.52M
6.29M
2.29M
917K
1.86M
1.22M
0
0
0
Operating revenue
44.21%2.69M
106.39%2.52M
--6.29M
--2.29M
--917K
--1.86M
--1.22M
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-35.30%20.13M
-26.88%21.73M
-6.56%128.12M
-12.03%29.63M
3.59%34.74M
-7.20%31.12M
-18.29%29.71M
-9.43%137.12M
-46.03%33.68M
-0.40%33.54M
Selling and administrative expenses
-38.22%6.37M
-25.36%7.51M
-3.83%41.74M
3.92%10.93M
-7.27%9.4M
-4.78%10.31M
-15.69%10.06M
12.74%43.4M
-9.26%10.51M
12.80%10.14M
-General and administrative expense
-38.22%6.37M
-25.36%7.51M
-3.83%41.74M
3.92%10.93M
-7.27%9.4M
-4.78%10.31M
-15.69%10.06M
12.74%43.4M
-9.26%10.51M
12.80%10.14M
Research and development costs
-33.85%13.77M
-27.65%14.22M
-7.83%86.38M
-19.27%18.7M
8.29%25.34M
-8.35%20.81M
-19.56%19.66M
-17.00%93.72M
-54.41%23.17M
-5.20%23.4M
Operating profit
40.36%-17.45M
32.59%-19.21M
11.15%-121.83M
18.82%-27.34M
-0.86%-33.83M
12.76%-29.25M
21.65%-28.49M
9.43%-137.12M
46.03%-33.68M
0.40%-33.54M
Net non-operating interest income expense
-24.89%1.82M
-9.71%2.04M
134.13%9.16M
6.53%2.02M
91.19%2.45M
287.08%2.43M
2,110.78%2.26M
1,122.19%3.91M
2,538.89%1.9M
1,731.43%1.28M
Non-operating interest income
-24.89%1.82M
-9.71%2.04M
134.13%9.16M
6.53%2.02M
91.19%2.45M
287.08%2.43M
2,110.78%2.26M
1,122.19%3.91M
2,538.89%1.9M
1,731.43%1.28M
Other net income (expense)
80.18%-578K
-12.79M
-2.92M
Special income (charges)
80.18%-578K
---12.79M
----
----
----
---2.92M
--0
----
----
----
Income before tax
45.53%-16.2M
-14.18%-29.96M
15.41%-112.67M
20.33%-25.32M
2.73%-31.37M
9.61%-29.74M
27.65%-26.24M
11.83%-133.2M
49.01%-31.78M
4.01%-32.26M
Income tax
Net income
45.53%-16.2M
-14.18%-29.96M
15.41%-112.67M
20.33%-25.32M
2.73%-31.37M
9.61%-29.74M
27.65%-26.24M
11.83%-133.2M
49.01%-31.78M
4.01%-32.26M
Net income continuous Operations
45.53%-16.2M
-14.18%-29.96M
15.41%-112.67M
20.33%-25.32M
2.73%-31.37M
9.61%-29.74M
27.65%-26.24M
11.83%-133.2M
49.01%-31.78M
4.01%-32.26M
Minority interest income
Net income attributable to the parent company
45.53%-16.2M
-14.18%-29.96M
15.41%-112.67M
20.33%-25.32M
2.73%-31.37M
9.61%-29.74M
27.65%-26.24M
11.83%-133.2M
49.01%-31.78M
4.01%-32.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
45.53%-16.2M
-14.18%-29.96M
15.41%-112.67M
20.33%-25.32M
2.73%-31.37M
9.61%-29.74M
27.65%-26.24M
11.83%-133.2M
49.01%-31.78M
4.01%-32.26M
Basic earnings per share
48.08%-0.27
-8.70%-0.5
17.72%-1.95
23.21%-0.43
5.26%-0.54
11.86%-0.52
29.23%-0.46
14.13%-2.37
50.44%-0.56
6.56%-0.57
Diluted earnings per share
48.08%-0.27
-8.70%-0.5
17.72%-1.95
23.21%-0.43
5.26%-0.54
11.86%-0.52
29.23%-0.46
14.13%-2.37
50.44%-0.56
6.56%-0.57
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 44.21%2.69M106.39%2.52M6.29M2.29M917K1.86M1.22M000
Operating revenue 44.21%2.69M106.39%2.52M--6.29M--2.29M--917K--1.86M--1.22M--0--0--0
Cost of revenue
Gross profit
Operating expense -35.30%20.13M-26.88%21.73M-6.56%128.12M-12.03%29.63M3.59%34.74M-7.20%31.12M-18.29%29.71M-9.43%137.12M-46.03%33.68M-0.40%33.54M
Selling and administrative expenses -38.22%6.37M-25.36%7.51M-3.83%41.74M3.92%10.93M-7.27%9.4M-4.78%10.31M-15.69%10.06M12.74%43.4M-9.26%10.51M12.80%10.14M
-General and administrative expense -38.22%6.37M-25.36%7.51M-3.83%41.74M3.92%10.93M-7.27%9.4M-4.78%10.31M-15.69%10.06M12.74%43.4M-9.26%10.51M12.80%10.14M
Research and development costs -33.85%13.77M-27.65%14.22M-7.83%86.38M-19.27%18.7M8.29%25.34M-8.35%20.81M-19.56%19.66M-17.00%93.72M-54.41%23.17M-5.20%23.4M
Operating profit 40.36%-17.45M32.59%-19.21M11.15%-121.83M18.82%-27.34M-0.86%-33.83M12.76%-29.25M21.65%-28.49M9.43%-137.12M46.03%-33.68M0.40%-33.54M
Net non-operating interest income expense -24.89%1.82M-9.71%2.04M134.13%9.16M6.53%2.02M91.19%2.45M287.08%2.43M2,110.78%2.26M1,122.19%3.91M2,538.89%1.9M1,731.43%1.28M
Non-operating interest income -24.89%1.82M-9.71%2.04M134.13%9.16M6.53%2.02M91.19%2.45M287.08%2.43M2,110.78%2.26M1,122.19%3.91M2,538.89%1.9M1,731.43%1.28M
Other net income (expense) 80.18%-578K-12.79M-2.92M
Special income (charges) 80.18%-578K---12.79M---------------2.92M--0------------
Income before tax 45.53%-16.2M-14.18%-29.96M15.41%-112.67M20.33%-25.32M2.73%-31.37M9.61%-29.74M27.65%-26.24M11.83%-133.2M49.01%-31.78M4.01%-32.26M
Income tax
Net income 45.53%-16.2M-14.18%-29.96M15.41%-112.67M20.33%-25.32M2.73%-31.37M9.61%-29.74M27.65%-26.24M11.83%-133.2M49.01%-31.78M4.01%-32.26M
Net income continuous Operations 45.53%-16.2M-14.18%-29.96M15.41%-112.67M20.33%-25.32M2.73%-31.37M9.61%-29.74M27.65%-26.24M11.83%-133.2M49.01%-31.78M4.01%-32.26M
Minority interest income
Net income attributable to the parent company 45.53%-16.2M-14.18%-29.96M15.41%-112.67M20.33%-25.32M2.73%-31.37M9.61%-29.74M27.65%-26.24M11.83%-133.2M49.01%-31.78M4.01%-32.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 45.53%-16.2M-14.18%-29.96M15.41%-112.67M20.33%-25.32M2.73%-31.37M9.61%-29.74M27.65%-26.24M11.83%-133.2M49.01%-31.78M4.01%-32.26M
Basic earnings per share 48.08%-0.27-8.70%-0.517.72%-1.9523.21%-0.435.26%-0.5411.86%-0.5229.23%-0.4614.13%-2.3750.44%-0.566.56%-0.57
Diluted earnings per share 48.08%-0.27-8.70%-0.517.72%-1.9523.21%-0.435.26%-0.5411.86%-0.5229.23%-0.4614.13%-2.3750.44%-0.566.56%-0.57
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data